REPARE THERAPEUTICS INC (RPTX) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:RPTX • US7602731025

2.65 USD
+0.02 (+0.76%)
At close: Jan 27, 2026
2.65 USD
0 (0%)
After Hours: 1/27/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
RPTX revenue by date.RPTX revenue by date.
131.8M
1,634.21%
51.133M
-61.20%
53.477M
4.58%
306K
-99.43%
6.8M
2,122.22%

-100.00%
EBITDA
YoY % growth
RPTX ebitda by date.RPTX ebitda by date.
-17.82M
83.38%
-114.273M
-541.26%
-90.223M
21.05%
-85.854M
4.84%
-91.451M
-6.52%
N/AN/AN/AN/A
EBIT
YoY % growth
RPTX ebit by date.RPTX ebit by date.
-19.8M
81.78%
-116.224M
-486.99%
-92.144M
20.72%
-99.068M
-7.51%
-32.028M
67.67%
-25.5M
20.38%
-26.52M
-4.00%
-27.54M
-3.85%
-28.56M
-3.70%
Operating Margin
RPTX operating margin by date.RPTX operating margin by date.
-15.02%-227.30%-172.31%-32,375.00%-471.00%N/AN/AN/AN/A
EPS
YoY % growth
RPTX eps by date.RPTX eps by date.
-0.78
72.34%
-2.23
-185.90%
-2.00
10.31%
-2.15
-7.61%
-0.74
65.40%
-0.61
17.81%
-0.29
53.33%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth
-0.43
36.06%
-0.29
53.37%
-0.17
62.21%
-0.14
-457.00%
Revenue
Q2Q % growth
2.55M1.7M1.7M1.7M
-85.37%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-20.073M
34.82%
-12.648M
54.70%
-7.14M
64.41%
-6.12M
-1,323.26%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.04
104.94%
-0.120.16133.81%
Q2 2025
Q2Q % growth
-0.44
46.34%
-0.570.1322.90%
Q1 2025
Q2Q % growth
-0.63
-310.00%
-0.670.045.70%
Q4 2024
Q2Q % growth
-0.67 -0.800.1316.77%
Q3 2024
Q2Q % growth
-0.81
-80.00%
-0.890.088.83%
Q2 2024
Q2Q % growth
-0.82
-192.86%
-0.890.077.44%
Q1 2024
Q2Q % growth
0.30
136.14%
0.020.281,772.17%
Q4 2023
Q2Q % growth
-0.67
10.67%
-0.37-0.30-83.19%
Q3 2023
Q2Q % growth
-0.45
-126.32%
-0.880.4348.63%
Q2 2023
Q2Q % growth
-0.28
69.23%
-0.800.5264.81%
Q1 2023
Q2Q % growth
-0.83 -0.82-0.01-0.64%
Q4 2022
Q2Q % growth
-0.75
-7.14%
-0.74-0.01-1.88%
Q3 2022
Q2Q % growth
1.71
306.02%
-0.912.62288.79%
Q2 2022
Q2Q % growth
-0.91
-28.17%
-0.86-0.05-5.37%
Q1 2022
Q2Q % growth
-0.83
-43.10%
-0.870.044.91%
Q4 2021
Q2Q % growth
-0.70
-70.73%
-0.750.057.26%
Q3 2021
Q2Q % growth
-0.83
-124.32%
-0.72-0.11-14.61%
Q2 2021
Q2Q % growth
-0.71
71.02%
-0.62-0.09-15.05%
Q1 2021
Q2Q % growth
-0.58 -0.52-0.06-12.38%
Q4 2020
Q2Q % growth
-0.41 -0.40-0.01-1.76%
Q3 2020
Q2Q % growth
-0.37 -0.390.024.12%
Q2 2020
Q2Q % growth
-2.45 -0.06-2.39-4,077.32%
RPTX Yearly EPS VS EstimatesRPTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
11.62M 7.65M3.97M51.90%
Q2 2025
Q2Q % growth
250K
-100.00%
%
Q1 2025
Q2Q % growth

-100.00%
2.55M-2.55M-100.00%
Q4 2024
Q2Q % growth

-100.00%
2.788M-2.788M-100.00%
Q3 2024
Q2Q % growth

-100.00%
2.788M-2.788M-100.00%
Q2 2024
Q2Q % growth
1.073M
-96.45%
2.983M-1.91M-64.03%
Q1 2024
Q2Q % growth
52.404M
822.93%
39.168M13.236M33.79%
Q4 2023
Q2Q % growth
13.047M
-28.31%
19.309M-6.262M-32.43%
Q3 2023
Q2Q % growth
2.159M
-98.08%
6.436M-4.277M-66.45%
Q2 2023
Q2Q % growth
30.249M
4,221.29%
7.837M22.412M285.98%
Q1 2023
Q2Q % growth
5.678M
1,319.50%
6.242M-564K-9.04%
Q4 2022
Q2Q % growth
18.2M
163.77%
8.279M9.921M119.83%
Q3 2022
Q2Q % growth
112.5M
37,400.00%
1.612M110.888M6,878.91%
Q2 2022
Q2Q % growth
700K
133.33%
1.989M-1.289M-64.81%
Q1 2022
Q2Q % growth
400K
100.00%
2.399M-1.999M-83.33%
Q4 2021
Q2Q % growth
6.9M
6,800.00%
3.342M3.558M106.46%
Q3 2021
Q2Q % growth
300K 142.657K157.343K110.29%
Q2 2021
Q2Q % growth
300K 612K-312K-50.98%
Q1 2021
Q2Q % growth
200K 637.5K-437.5K-68.63%
Q4 2020
Q2Q % growth
100K 1.275M-1.175M-92.16%
Q3 2020
Q2Q % growth
1.02M-1.02M-100.00%
Q2 2020
Q2Q % growth
17M-17M-100.00%
RPTX Yearly Revenue VS EstimatesRPTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -83.41% 0% -49.86%
Revenue0% 0% 0% -97.09%